GBP1 and prostate cancer: To explore the possible role of GBP1 in prostate cancer, stable DU145 GBP1 KO and PC3 GBP1 KO cell lines were established using the CRISPR/Cas9 technology, in which one nucleotide mutation and early terminator were created in exon2 in both cell lines.